National biotech industry meeting reflects growth in Oklahoma sector

Creating a startup in bioscience is different than creating a startup in any other industry. For starters, the research and invention can take years, writes Scott Meacham, president and CEO of i2E Inc.

Published: Monday, July 13, 2015 By: Scott Meacham

Creating a startup in bioscience is different than creating a startup in any other industry.

For starters, the research and invention can take years.

Last week I wrote about Biolytx, an Oklahoma startup that is on a track to concluding clinical testing. It’s taken three decades of devotion and effort for Dr. Anne Pereira to identify and validate a new drug for fighting antibiotic-resistant bacteria, and the company has another few years (at least) to go with completing clinical testing and progressing through clinical trials.

Read more on NewsOK.

Back to top